Disease | c syndrome |
Phenotype | C0020443|hypercholesterolemia |
Sentences | 8 |
PubMedID- 23755078 | The adjusted odds ratios (ors) for hypertension, diabetes mellitus, hypercholesterolemia, smoking, metabolic syndrome and chronic kidney disease were significantly higher in subjects with pad or cad compared to those in control. |
PubMedID- 23573368 | Heavy proteinuria (nephrotic syndrome) is associated with hypercholesterolemia, hypertriglyceridemia and a high risk of atherosclerosis. |
PubMedID- 20425579 | Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the vymet study. |
PubMedID- 25880551 | hypercholesterolemia is one of metabolic syndromes characterized by the high level of plasma cholesterol. |
PubMedID- 22458400 | Rapid amelioration of hypercholesterolemia in nephrotic syndrome (ns) using low density lipoprotein-apheresis (ldl-a) sometimes leads to ns remission, along with improvement of impaired biodefense system; however, the mechanism of how ldl-a affects ns is still unknown. |
PubMedID- 21616679 | Conclusions: our results suggest that the g-308a polymorphism of the tnf-alpha gene may be independently associated with hypertension, leptin level and hypercholesterolemia leading to metabolic syndrome independent of insulin resistance and hyperglycemia. |
PubMedID- 22210379 | Mitoq administered orally for 14weeks prevented the increased adiposity, hypercholesterolemia, and hypertriglyceridemia associated with the metabolic syndrome. |
PubMedID- 22082322 | Anacetrapib is a cholesteryl-ester-transfer-protein (cetp) inhibitor, a new class of experimental drugs in the treatment of primary hypercholesterolemia and dyslipidaemia associated with the metabolic syndrome. |
Page: 1